PCN17 ESTIMATING THE COST SAVINGS FROM THE INTRODUCTION OF KRAS TESTING IN THE MANAGEMENT OF METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECEIVING PANITUMUMAB IN GREECE
Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66554-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)66554-0/fulltext
Section Title :
Section Order :
389
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66554-0&doi=10.1016/S1098-3015(10)66554-0